Correlation Between Oncolytics Biotech and Surrozen
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Surrozen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Surrozen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Surrozen, you can compare the effects of market volatilities on Oncolytics Biotech and Surrozen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Surrozen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Surrozen.
Diversification Opportunities for Oncolytics Biotech and Surrozen
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Oncolytics and Surrozen is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Surrozen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Surrozen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Surrozen go up and down completely randomly.
Pair Corralation between Oncolytics Biotech and Surrozen
Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the Surrozen. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 2.56 times less risky than Surrozen. The stock trades about -0.26 of its potential returns per unit of risk. The Surrozen is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 1,040 in Surrozen on August 24, 2024 and sell it today you would lose (110.00) from holding Surrozen or give up 10.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncolytics Biotech vs. Surrozen
Performance |
| Timeline |
| Oncolytics Biotech |
| Surrozen |
Oncolytics Biotech and Surrozen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncolytics Biotech and Surrozen
The main advantage of trading using opposite Oncolytics Biotech and Surrozen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Surrozen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will offset losses from the drop in Surrozen's long position.| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
| Surrozen vs. Lyra Therapeutics | Surrozen vs. Hookipa Pharma | Surrozen vs. Cingulate Warrants | Surrozen vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |